Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -1.32% | -4.76% | -9.64% |
Apr. 12 | Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating | MT |
Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
Financials (USD)
Sales 2024 * | 1.02M | Sales 2025 * | 22.93M | Capitalization | 251M |
---|---|---|---|---|---|
Net income 2024 * | -137M | Net income 2025 * | -138M | EV / Sales 2024 * | 246 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.9 x |
P/E ratio 2024 * |
-1.49
x | P/E ratio 2025 * |
-1.62
x | Employees | 159 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.51% |
1 day | +4.47% | ||
1 week | +2.70% | ||
Current month | +4.47% | ||
1 month | -24.94% | ||
3 months | -28.13% | ||
6 months | +104.03% | ||
Current year | -8.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | Dec. 03 | |
Douglas Carr
DFI | Director of Finance/CFO | - | 18-09-30 |
Kenneth J. Dow
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 22-09-30 |
Joseph Jimenez
CHM | Chairman | 64 | 19-07-31 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 21-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +5.00% | - | |
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 3 | -1.32% | 116 134 |
24-05-01 | 3.04 | +4.47% | 109,778 |
24-04-30 | 2.91 | -4.59% | 166,629 |
24-04-29 | 3.05 | +5.90% | 102,231 |
24-04-26 | 2.88 | -8.57% | 161,095 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.43% | 251M | |
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- IPSC Stock